Gobi Partners, via its SuperSeed II Fund, has spearheaded an undisclosed pre-seed investment in Valiance Health Inc., Malaysia's innovative AI healthcare company.
The funding round also attracted participation from Jati Growth and Artem Ventures, marking a significant milestone for regional health tech.
Founders' Vision and Healthcare Challenges
Valiance Health emerged from co-founder Dr. Lutfi Fadil's Harvard doctoral research in 2019, which highlighted data fragmentation as the key barrier to value-based care in Malaysia.
Co-founder Dr. Ridhwan Hassan, formerly at KPJ Healthcare Berhad, experienced firsthand the issues of inconsistent coding and legacy systems impeding efficiency.
Cutting-Edge AI Platform and Proven Impact
The company's platform aggregates clinical, operational, and financial data from hospitals, using AI to standardize it into an internationally recognized model.
Healthproximate, Valiance's analytics tool, empowers providers with insights into costs and operations, helping Avisena Healthcare achieve approximately $22,000 in annual savings on procedures like appendicectomies.
Since inception, Valiance has onboarded several private hospitals and a major third-party administrator, with more partnerships in the pipeline.
Gobi Partners' Strategic Bet on SEA Health AI
This investment represents Gobi Partners' inaugural foray into healthcare AI in Southeast Asia, reinforcing their focus on data-led, impact-driven innovations.
“Malaysia’s healthcare system is at an inflection point. Valiance is addressing the core data problem that has long slowed the shift to value-based care,” said Jamaludin Bujang, managing partner at Gobi Partners.
Dr. Lutfi Fadil, CEO of Valiance Health, noted that standardized data is essential for Malaysia to transition from fragmented reporting to evidence-based healthcare.
The funds will expand the team, enhance AI pipelines, integrate with more systems, and forge collaborations with insurers and administrators.
Ultimately, Valiance aims to catalyze Malaysia's evolution toward transparent, efficient, and value-driven care, reducing administrative burdens and enabling better outcomes amid rising medical inflation.
Andrew Lee
